Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-09-20 4:15 pm Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 11,709,117 54.950% | 6,360,888 (+118.93%) | View |
| 2024-06-25 4:15 pm Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 5,348,229 53.500% | 5,348,229 (New Position) | View |
| 2022-12-29 7:43 pm Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 12,429,353 65.500% | 12,333,333 (+12844.55%) | View |
| 2022-11-10 4:14 pm Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 96,020 2.400% | 96,020 (New Position) | View |
| 2022-09-16 4:46 pm Sale | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 96,020 10.700% | -2,784,592 (-96.67%) | View |
| 2021-09-01 4:20 pm Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 12.900% | 0 (Unchanged) | View |
| 2021-08-27 9:11 pm Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 12.900% | 0 (Unchanged) | View |
| 2021-03-11 06:08 am Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 13.000% | 0 (Unchanged) | View |
| 2020-01-09 4:52 pm Purchase | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 18.500% | 2,880,612 (New Position) | View |